H107e/CAF®10b

Tuberculosis vaccine candidate H107e with CAF10b adjuvant · Statens Serum Institut

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H107e/CAF®10b, covering 2026-03-10 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10b [Phase 1]